According to Focus Report's latest research report, the global ophthalmic implants market is growing at a CAGR of 7.48% ...

On the heels of its FDA approval, clinicians weigh in on acoltremon’s (Tryptry) novel mechanism of action and its potential ...

With the recently launched Unity system, Alcon aims to allow ophthalmologists to perform vitreoretinal cataract surgery and ...

Vera, a new handheld rebound tonometer, closely align with those taken with the Ocular Response Analyzer, according to a ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced a voluntary recall of intraocular lenses (IOLs) ...

GENEVA, May 28, 2025--Alcon Announces FDA Approval of TRYPTYR (acoltremon ophthalmic solution) 0.003% for the Treatment of the Signs and Symptoms of Dry Eye Disease ...

Direct selective laser trabeculoplasty is not yet noninferior to SLT in lowering IOP, but secondary endpoints show promise.